Display options
Share it on

Bioinformation. 2009 Nov 17;4(5):216-22. doi: 10.6026/97320630004216.

Molecular cloning, sequence analysis and homology modeling of galE encoding UDP-galactose 4-epimerase of Aeromonas hydrophila.

Bioinformation

Shivani Agarwal, Keshav Gopal, Gagan Chhabra, Aparna Dixit

Affiliations

  1. Gene Regulation Laboratory, School of Biotechnology, Jawaharlal Nehru University, New Delhi - 110067, India.

PMID: 20461162 PMCID: PMC2859578 DOI: 10.6026/97320630004216

Abstract

A. hydrophila, a ubiquitous gram-negative bacterium present in aquatic environments, has been implicated in illness in humans, fish and amphibians. Lipopolysaccharides (LPS), a surface component of the outer membrane, are one of the main virulent factors of gram-negative bacteria. UDP-galactose 4-epimerase (GalE) catalyses the last step in the Leloir pathway of galactose metabolism and provides precursor for the biosynthesis of extracellular LPS and capsule. Due to its key role in LPS biosynthesis, it is a potential drug target. The present study describes cloning, sequence analysis and prediction of three dimensional structure of the deduced amino acid sequence of the galE of A. hydrophila AH17. The cloned galE consists of the putative promoter-operator region, and an open reading frame of 338 amino acid residues. Sequence alignment and predicted 3Dstructure revealed that the GalE of A. hydrophila consists of the signature sequences of the epimerase super family. The present study reports the molecular modeling / 3D-structure prediction of GalE of A. hydrophila. Further, the potential regions of the enzyme that can be targeted for drug design are identified.

Keywords: Aeromonas hydrophila; UDP-galactose 4- epimerase; lipopolysaccharide; molecular phylogenetic; virulence

References

  1. Infect Immun. 1996 Mar;64(3):855-60 - PubMed
  2. J Infect Dis. 1975 May;131(5):553-8 - PubMed
  3. Infect Immun. 2001 Jan;69(1):435-45 - PubMed
  4. J Mol Graph. 1990 Mar;8(1):52-6, 29 - PubMed
  5. Clin Infect Dis. 1998 Aug;27(2):332-44 - PubMed
  6. J Bacteriol. 1996 Oct;178(20):5916-24 - PubMed
  7. Can J Vet Res. 1986 Apr;50(2):165-73 - PubMed
  8. Biochemistry. 1997 Sep 2;36(35):10675-84 - PubMed
  9. Infect Immun. 2000 May;68(5):2594-601 - PubMed
  10. Nucleic Acids Res. 1994 Nov 11;22(22):4673-80 - PubMed
  11. Clin Microbiol Rev. 1991 Oct;4(4):397-410 - PubMed
  12. Methods Enzymol. 1997;277:396-404 - PubMed
  13. Adv Protein Chem. 1968;23:283-438 - PubMed
  14. J Bacteriol. 2007 Jan;189(2):540-50 - PubMed
  15. Curr Microbiol. 1998 Aug;37(2):144-8 - PubMed
  16. Infect Immun. 2006 Jan;74(1):537-48 - PubMed
  17. Nucleic Acids Res. 2003 Jul 1;31(13):3381-5 - PubMed
  18. Microb Pathog. 1996 Jun;20(6):325-33 - PubMed
  19. Biochemistry. 2000 May 16;39(19):5691-701 - PubMed
  20. J Bacteriol. 1990 Aug;172(8):4392-8 - PubMed
  21. J Biol Chem. 2003 Nov 7;278(45):43885-8 - PubMed
  22. Infect Immun. 2002 May;70(5):2326-35 - PubMed
  23. DNA Seq. 2007 Aug;18(4):302-6 - PubMed
  24. J Biol Chem. 2001 May 4;276(18):15131-6 - PubMed

Publication Types